Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 5,802.3 | 5,045.2 | 4,642.1 | 4,609.8 | 4,285.3 | 4,285.3 | 2,531.2 | 2,538.9 |
| Revenue growth | 15.0% | 8.7% | 0.7% | 7.6% | 69.3% | | -0.3% | 1.9% |
| Cost of goods sold | 3,475.5 | 2,883.9 | 2,595.4 | 2,526.2 | 2,405.5 | 2,405.5 | 1,579.4 | 1,607.7 |
| Gross profit | 2,326.8 | 2,161.3 | 2,046.7 | 2,083.6 | 1,879.8 | 1,879.8 | 951.8 | 931.2 |
| Gross margin | 40.1% | 42.8% | 44.1% | 45.2% | 43.9% | 43.9% | 37.6% | 36.7% |
| Selling, general and administrative | 775.2 | 714.1 | 729.7 | 792.9 | 790.0 | 790.0 | 581.7 | 435.1 |
| Research and development | 314.2 | 304.7 | 287.9 | 298.1 | 287.7 | 287.7 | 138.4 | 134.5 |
| EBITA | 1,298.0 | 1,205.2 | 1,091.0 | 1,055.2 | 864.4 | 802.7 | 258.6 | 409.1 |
| EBITA margin | 22.4% | 23.9% | 23.5% | 22.9% | 20.2% | 18.7% | 10.2% | 16.1% |
| Amortization of intangibles | 60.6 | 62.7 | 61.9 | 62.6 | 62.2 | | 26.8 | 23.6 |
| EBIT | 1,237.4 | 1,142.5 | 1,029.1 | 992.6 | 802.2 | 802.7 | 231.8 | 385.5 |
| EBIT margin | 21.3% | 22.6% | 22.2% | 21.5% | 18.7% | 18.7% | 9.2% | 15.2% |
| Pre-tax income | 983.9 | 897.8 | 731.0 | 655.0 | 608.4 | 608.4 | 95.8 | 180.8 |
| Income taxes | 145.2 | 92.5 | 151.2 | 111.5 | 70.8 | 70.8 | 228.9 | 50.1 |
| Tax rate | 14.8% | 10.3% | 20.7% | 17.0% | 11.6% | 11.6% | 238.9% | 27.7% |
| Earnings from continuing ops | 1,672.4 | 1,613.1 | 1,160.5 | 1,084.2 | 1,065.8 | 531.4 | -135.7 | 128.1 |
| Earnings from discontinued ops | -97.2 | -68.2 | -28.3 | -63.3 | -26.1 | -29.3 | 671.5 | 81.0 |
| Net income | 1,575.2 | 1,544.9 | 1,132.2 | 1,020.9 | 1,039.7 | 502.1 | 535.8 | 209.1 |
| Net margin | 27.1% | 30.6% | 24.4% | 22.1% | 24.3% | 11.7% | 21.2% | 8.2% |
| |
| Diluted EPS | $13.20 | $12.49 | $8.89 | $8.21 | $7.84 | $3.91 | ($1.01) | $0.95 |
| Shares outstanding (diluted) | 126.7 | 129.1 | 130.6 | 132.0 | 135.9 | 136.1 | 134.3 | 134.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|